Discover G4X Spatial Sequencing

The G4X Spatial Sequencer is a high-throughput in-situ multiomic platform enabling spatial research at scale through its early access technology services. You can now get cost-effective transcriptomic and proteomic analysis from FFPE samples at subcellular resolution.

Introducing High-Throughput Spatial Multiomics

G4X Technology Services

Unlock insights with our immuno-oncology transcriptomic and proteomic panels or customize panels for your research project.

  • Targeted Transcriptomics
  • Targeted Proteomics
  • Fluorescent H&E

Check Out G4X Data

Sequencing-Based High-Throughput Imaging of Proteins and RNA in FFPE Tissue Sections

See the data to learn how high-throughput spatial sequencing with the G4X™ is enabling researchers to produce multi-modal spatial images from challenging patient samples.

Get Started with G4X

Please provide your information and a member of the Singular Genomics team will be in contact with additional G4X details.

Download G4X Product Flyer

Please provide your information to access and download the flyer.

Download the Project Tiers Flyer

Please provide your information to download the flyer.

Drew Spaventa

Drew founded Singular Genomics in 2016 serving as the CEO and Chairman. Drew is a serial entrepreneur and venture investor in the biotech industry and has been involved in the founding of several successful companies. Prior to Singular Genomics, Drew founded Truvian Sciences, a low volume blood testing technology aimed at making routine blood tests easier, less invasive, and more affordable. Drew was also involved in the founding of Aspen Neurosciences where he co-led the seed financing and helped assemble a world-class team to combat Parkinson’s Disease using a patient’s own stem cells. Drew was also a seed investor and held an operating role in Edico Genome which sold to Illumina in 2018.

Drew received an MBA from the Rady School of Management at the University of California, San Diego and a BA in Political Science and International Relations from the University of California, San Diego.

Max Reads Application Note